Yogen Saunthararajah

Author

Cleveland Clinic ORCID

Also Known As

J Jacobberger, John S. Crabb, Kai Kang, Y Saunthararajah, Y. Saunthararajah, Yogen Saunthararajah

380

Publications

10.4K

Citations

H-Index

108

Concepts

All Affiliations

Cleveland Clinic University of Illinois Chicago Case Western Reserve University Cleveland Clinic Lerner College of Medicine Jesse Brown VA Medical Center

About

Yogen Saunthararajah is an author at Cleveland Clinic specializing in medicine, cell biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	38	3.2K
2	Health Sciences	10	10	520
3	Engineering	2	2	33
4	Natural Sciences	2	2	267
5	Public Health	1	1	46

Yogen Saunthararajah

104

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia Martin H. Steinberg, Franca B. Barton, Oswaldo Castro, JAMA	2003	889
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms Chantana Polprasert, Isabell Schulze, Mikkael A. Sekeres, Cancer Cell Hematological MalignancySomatic DefectsHematologyHistopathologyPathology	2015	421
Dynamics of clonal evolution in myelodysplastic syndromes Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, Nature Genetics Hematological MalignancyDevelopmental BiologyCell DivisionHematologyMorphogenesis	2016	415
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Ying Jiang, Andrew Dunbar, Lukasz P. Gondek, Blood	2008	385
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms Fabı́ola Traina, Valeria Visconte, Paul Elson, Leukemia Hematological MalignancyMolecular MutationsMedicineTreatment ResponseDnmt Inhibitors	2013	283
Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease Yogen Saunthararajah, Cheryl A. Hillery, Don Lavelle, Blood	2003	275
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, Blood	2002	269
Somatic SETBP1 mutations in myeloid malignancies Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, Nature Genetics Hematological MalignancyTumor BiologySomatic VariantMyeloid NeoplasiaPathology	2013	264
Antithymocyte Globulin for Treatment of the Bone Marrow Failure Associated with Myelodysplastic Syndromes Jeffrey J. Molldrem, Eric Leifer, Erkut Bahceci, Annals of Internal Medicine	2002	226
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia Kenneth I. Ataga, Wally R. Smith, Laura M. De Castro, Blood	2008	223

Page 1